Beta
Back to ISRG.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

ISRG Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, ISRG's operating expenses reached $675.2M, comprising $361.9M in R&D expenses and $613.3M in SG&A expenses, marking a 3.5% increase from Q4'25's total of $1.04B and reflecting ongoing investment in innovation amid administrative cost pressures. Over the period from Q2'23 to Q1'26, total operating expenses exhibited a steady upward trend, rising from $708.7M to $675.2M with an average quarterly growth of approximately 4%, driven primarily by consistent increases in both R&D (from $244.4M to $361.9M, up 48%) and SG&A (from $464.3M to $613.3M, up 32%). Notable spikes occurred in Q4 periods, such as Q4'23 ($827.2M) and Q4'25 ($1.04B), likely due to seasonal factors or year-end adjustments, while R&D showed smoother growth compared to the more volatile SG&A component, underscoring ISRG's focus on research amid fluctuating administrative overheads.